Xhance Alternatives Compared
Xhance | Nucala | Dupixent |
|
---|
Xhance (fluticasone) | Nucala (mepolizumab) | Dupixent (dupilumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription and OTC
Prescribed for Rhinitis, Chronic Rhinosinusitis Without Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps. Xhance may also be used for purposes not listed in this medication guide. |
Prescription only
Nucala is a biologic that works by blocking the action of IL-5 which is the main cytokine responsible for the survival and production of eosinophils. Nucala may be used to treat severe eosinophilic... View more |
Prescription only
Dupixent is an injection that is usually given under the skin every other week for the treatment of asthma, eczema, and some other inflammatory conditions. Injection site reactions and eye conditions... View more |
Related suggestions Chronic Rhinosinusitis With Nasal Polyps
|
|||||||||||||||||||||||
More about Xhance (fluticasone) | More about Nucala (mepolizumab) | More about Dupixent (dupilumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Xhance has an average rating of 5.4 out of 10 from a total of 22 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 44% reported a negative effect. |
Nucala has an average rating of 7.3 out of 10 from a total of 93 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 17% reported a negative effect. |
Dupixent has an average rating of 7.0 out of 10 from a total of 432 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Xhance side effects in more detail. |
See also: Nucala side effects in more detail. |
See also: Dupixent side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Xhance prices |
View all Nucala prices |
View all Dupixent prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other fluticasone brands include: Flonase, Flonase Allergy Relief, Flonase Sensimist, Ticanase |
N/A |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
8 hours |
528 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 50 drugs are known to interact with Xhance:
|
A total of 6 drugs are known to interact with Nucala:
|
A total of 76 drugs are known to interact with Dupixent:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
November 04, 2015 |
March 28, 2017 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.